CHLA Clinical Research Studies

Having volunteers participate in research studies and clinical trials is critical to our research efforts. Thousands of children and families are involved in our patient-centered studies every year. Many of the treatments used today are based on the results of past research studies and clinical trials conducted with our patients. Our scientific and clinical experts take the best ideas from the laboratory -- to the patient -- in the form of promising new treatments.

By searching our study directory, you may identify research that could impact the life of your child or of another child you know. Because the number of available research studies and clinical trials for children nationwide is small, every participant makes a significant contribution.

In addition to enrolling children with certain diseases in order to study treatments and prevention of those diseases, we also need to study healthy children. Ask your child’s doctor about volunteer study options that may be suitable for your child.

Please contact the study staff listed in your search results for more information.

Search by Keyword:    

Back to the full listing

Study Details - ID: CHLA-21-00318
Health/Science/Disease Category:
Tuberous Sclerosis Complex (TSC)
Purpose of Research:
Two main purposes of the study: (1) to see if social communication of children with TSC can be improved with a short term behavioral intervention (JASPER) and (2) to see if these improvements remain long after the study, and whether they can be observed with electroencephalography (EEG).
Short Name:
JETS
Full Title of Study:
JASPER Early Intervention for Tuberous Sclerosis (JETS)
Phase/Type of Study:
Behavioral Intervention
Eligibility:
Children ages 12-36 months with a TSC diagnosis*. , If your child is not yet 12 months of age, you may still begin the enrollment process; if your child is older than 36 months, you may be eligible for a single time-point assessment.
Time Commitment/Requirements:
Children between ages of 12 and 36 months: Four visits over 18-21 months. At least one visit must be in-person at CHLA, and the remaining visits may be in-person or remote. Visits will include behavioral assessments and EEG. A primary caregiver must be available to attend these sessions. JASPER behavioral intervention consists of 12 consecutive weekly sessions, with up to four occurring in person and the remainder done remotely., Children over 36 months: One in-person visit at CHLA including behavioral assessments and EEG.
Primary Investigator:
Shafali Spurling Jeste, MD
Coordinator Contact Name:
Andrew Smith
Phone Number:
323-361-1472
Email:
andsmith@chla.usc.edu
Clinical Trials .Gov Identifier:
NCT03422367